Sign Out
Gefitinib Genepharm contains the active substance gefitinib which blocks a protein called 'epidermal growth factor receptor' (EGFR). This protein is involved in the growth and spread of cancer cells.
Gefitinib Genepharm is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK.
